High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI

OBJECTIVE: Inflammation has emerged as a new treatment target in patients with coronary artery disease and inflammation seems to play an important role in ischaemia/reperfusion injury that follows ST-elevation myocardial infarction (STEMI). We aimed to explore the role of acute and sustained interle...

Descripción completa

Detalles Bibliográficos
Autores principales: Tøllefsen, Ingvild Maria, Shetelig, Christian, Seljeflot, Ingebjørg, Eritsland, Jan, Hoffmann, Pavel, Andersen, Geir Øystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693166/
https://www.ncbi.nlm.nih.gov/pubmed/34933964
http://dx.doi.org/10.1136/openhrt-2021-001869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693166/
https://www.ncbi.nlm.nih.gov/pubmed/34933964
http://dx.doi.org/10.1136/openhrt-2021-001869

Ejemplares similares